OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.470
+0.070 (5.00%)
Mar 4, 2026, 3:38 PM EST - Market open
OS Therapies Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OS Therapies stock have an average target of 18.5, with a low estimate of 17 and a high estimate of 20. The average target predicts an increase of 1,158.50% from the current stock price of 1.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OS Therapies stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,260.54% | Feb 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,260.54% | Jan 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,260.54% | Dec 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,260.54% | Dec 9, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,260.54% | Dec 5, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
10.63M
EPS This Year
-0.71
from -0.88
EPS Next Year
-0.44
from -0.71
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 17.9M | ||||
| Avg | n/a | 10.6M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.65 | -0.13 | ||||
| Avg | -0.71 | -0.44 | ||||
| Low | -0.74 | -0.81 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.